Not sure it is bad or good, certainly not great news. They have pushed Phase 2 start to 1st quarter of 2022, and made it a 12 month trial. Appears to me that they made up some positive words to mask the bad news of delay.
Ann: Expanded ATH434 Phase 2 Clinical Development Program, page-11
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $8.75K | 1.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 63306661 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28430837 | 21 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |